1. Home
  2. GANX vs HOVR Comparison

GANX vs HOVR Comparison

Compare GANX & HOVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.91

Market Cap

78.2M

Sector

Health Care

ML Signal

HOLD

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$2.38

Market Cap

80.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GANX
HOVR
Founded
2017
2013
Country
United States
Canada
Employees
N/A
30
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
78.2M
80.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GANX
HOVR
Price
$1.91
$2.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$7.50
$10.33
AVG Volume (30 Days)
534.8K
980.6K
Earning Date
05-13-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
31.46
N/A
EPS
N/A
N/A
Revenue
$55,180.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$0.45
52 Week High
$4.34
$4.18

Technical Indicators

Market Signals
Indicator
GANX
HOVR
Relative Strength Index (RSI) 46.29 68.73
Support Level $1.66 $1.70
Resistance Level $2.11 $2.50
Average True Range (ATR) 0.13 0.19
MACD -0.00 0.07
Stochastic Oscillator 38.82 79.53

Price Performance

Historical Comparison
GANX
HOVR

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

Share on Social Networks: